Sign in
Reply to comment on “Anastrozole (Arimidex ™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results” by H.T. Mouridsen, H.A. Chaudri-Ross
Journal article   Peer reviewed

Reply to comment on “Anastrozole (Arimidex ™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results” by H.T. Mouridsen, H.A. Chaudri-Ross

J.-M. Nabholtz
European journal of cancer (1990), Vol.40(7), pp.1097-1097
01/05/2004

Metrics

1 Record Views

Details